PARP1 and colorectal carcinoma: A significant downregulation of PARP1 levels was observed in NCM-460 cells following CN 75 μM treatment, while in both CRC cell lines (SW-620 and Caco-2) a consistent downregulation of PARP1 was detected with both treatments (Figure 12).